beta
Trial Radar AI
Clinical Trial NCT07354243 for Neuropathic Pain is not yet recruiting. See the Trial Radar Card View and AI discovery tools for all the details. Or ask anything here.
One study matched filter criteria
Card View
Back to Search

International Neuromodulation Registry 1,000 International Real-World Evidence

Not yet recruiting
Clinical Trial NCT07354243 is an observational study for Neuropathic Pain and is currently not yet recruiting. Enrollment is planned to begin on 5 January 2026 and continue until the study accrues 1,000 participants. Led by Poitiers University Hospital, this study is expected to complete by 31 December 2026. The latest data from ClinicalTrials.gov was last updated on 21 January 2026.
Brief Summary
The design and execution of the International Neuromodulation Society (INS) registry has been developed with the objective of assessing the efficacy and safety of Spinal Cord Stimulation and other neuromodulation therapies using real world data. The analysis of this registry as a data source will inform which therapies and devices are effective across clinics and participating countries.

It is designed to combine da...

Show More
Official Title

International Neuromodulation Registry

Conditions
Neuropathic Pain
Other Study IDs
  • INR Registry
NCT ID Number
NCT07354243
Start Date (Actual)
2026-01-05
Last Update Posted
2026-01-21
Completion Date (Estimated)
2026-12-31
Enrollment (Estimated)
1,000
Study Type
Observational
Status
Not yet recruiting
Arms / Interventions
Participant Group/ArmIntervention/Treatment
Neuromodulation therapies
Neuromodulation therapies
Spinal cord stimulation (SCS) procedures
Primary Outcome Measures
Outcome MeasureMeasure DescriptionTime Frame
Quality of life
The 5-level EQ-5D version (EQ-5D-5L) was introduced by the EuroQol Group in 2009 to improve the instrument's sensitivity and to reduce ceiling effects, as compared to the EQ-5D-3L. The EQ-5D-5L essentially consists of 2 pages: the EQ-5D descriptive system and the EQ visual analogue scale (EQ VAS). The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. This decision results in a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state.
12 Months
Participation Assistant
Eligibility Criteria

Eligible Ages
Adult, Older Adult
Minimum Age
18 Years
Eligible Sexes
All
  • Patients undergoing spinal cord stimulation (SCS) procedures
  • Obtain patient consent based on their local consent models

  • Patient unable to meet study requirements
Poitiers University Hospital logoPoitiers University Hospital
Study Central Contact
Contact: Tia SOFATZIS, 415 683 3237, [email protected]
No location data.